The health system ended the third quarter with operating income of $8.5 million, which exceeded Erlanger’s budget target by $1.3 million and the prior year by $7 million, according to the report.
Erlanger officials partially attributed the financial results to increased patient volumes. In total, admissions grew 12.4 percent in the third quarter, and heart surgeries in particular grew 61 percent year over year following launch of the health system’s heart and lung institute, according to the report.
Erlanger “East [Hospital] nearly tripled prior year volumes,” Erlanger CFO Britt Tabor said in the report.
“Overall, it was a very strong quarter for inpatient volumes for the entire health system,” he added.
More articles on healthcare finance:
9 recent hospital outlook and credit rating actions
Moody’s affirms ‘A2’ rating on Greater Baltimore Medical Center’s bonds
Letter to the editor: Cigarette tax is key for our community
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
